Noradrenergic response to intravenous yohimbine in patients with depression and comorbidity of depression and panic

Biological Psychiatry

Volumn 34, Issue 8, 1993, Pages 558-561

  Guthrie, Sally K ^a   Grunhaus, Leon ^b   Pande, Atul C ^c   Hariharan, M ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Comorbidity; depression; MHPG; norepinephrine; panic; yohimbine

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; NORADRENALIN; YOHIMBINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PANIC; PRIORITY JOURNAL;

ADULT; COMORBIDITY; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMAN; INFUSIONS, INTRAVENOUS; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGE; NOREPINEPHRINE; PANIC DISORDER; RECEPTORS, ADRENERGIC, ALPHA-2; YOHIMBINE;

EID: 0027378368     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(93)90199-N     Document Type: Article

References (13)

1. Noradrenergic function and the mechanism of action of antianxiety treatment II. The effect of long-term imipramine treatment
2. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks
3. Noradrenergic neuronal dysregulation in panic disorder the effects of intravenous yohimbine and clonidine in panic disorder patients
4. Simultaneous liquid chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines and 3,4-dihydroxyphenylalanine in plasma and their responses to inhibition of monoamine oxidase
5. Anxiety syndromes and their relationship to depressive illness
6. Sympathetic reactivity during a yohimbine challenge test in essential hypertension
7. Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers
8. Simultaneous panic and depressive disorders: Response to antidepressant treatments
9. Free 3methoxy-4-hydroxyphenylglycol determined in plasma by liquid chromatographly with coulometric detection
10. Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites
11. Panic disorder and major depression. increased risk of depression, alcoholism, panic, and phobic disorder panic disorder
12. 2-Adrenergic receptor function in depression. The cortisol response to yohimbine
13. The effect of yohimbine, WY 26392 and idazoxan on sympathetic nerve activity